Home/Filings/4/0001209191-17-053521
4//SEC Filing

Templeman Blaine 4

Accession 0001209191-17-053521

CIK 0001435049other

Filed

Sep 19, 8:00 PM ET

Accepted

Sep 20, 7:11 PM ET

Size

4.8 KB

Accession

0001209191-17-053521

Insider Transaction Report

Form 4
Period: 2017-09-18
Templeman Blaine
Executive VP, General Counsel
Transactions
  • Sale

    Common Stock

    2017-09-18$11.20/sh2,884$32,30158,834 total
Footnotes (1)
  • [F1]The sales reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2016.

Issuer

ADURO BIOTECH, INC.

CIK 0001435049

Entity typeother

Related Parties

1
  • filerCIK 0001653641

Filing Metadata

Form type
4
Filed
Sep 19, 8:00 PM ET
Accepted
Sep 20, 7:11 PM ET
Size
4.8 KB